Current Fungal Infection Reports

, Volume 4, Issue 4, pp 229–237 | Cite as

Pneumocystis Jirovecii Pneumonia: Current Knowledge and Outstanding Public Health Issues

  • Julie R. Harris
  • S. Arunmozhi Balajee
  • Benjamin J. Park


Antiretroviral therapy and cotrimoxazole prophylaxis have caused a decline in Pneumocystis jirovecii incidence in developing countries since the 1990s. Nevertheless, Pneumocystis jirovecii pneumonia (PCP) remains the primary AIDS-defining disease around the world. Much about the disease remains unknown, including its global burden, best diagnostic practices, the frequency of drug resistance, and the risks associated with Pneumocystis colonization. This review describes current knowledge about Pneumocystis infection and highlights areas where new research could benefit public health.


Pneumocystis PCP Jirovecii Carinii Pneumonia HIV Immunosuppressed Fungal DHPS Colonization Prophylaxis Oral washes 


Papers of particular interest, published recently, have been highlighted as:• Of importance•• Of major importance

  1. 1.
    Pifer LL, Hughes WT, Stagno S, Woods D: Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978, 61:35–41.PubMedGoogle Scholar
  2. 2.
    Goldman AS, Goldman LR, Goldman DA: What caused the epidemic of Pneumocystis pneumonia in European premature infants in the mid-20th century? Pediatrics 2005, 115:e725–e736.CrossRefPubMedGoogle Scholar
  3. 3.
    Morris A, Lundgren JD, Masur H, et al.: Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004, 10:1713–1720.PubMedGoogle Scholar
  4. 4.
    Hughes WT: Prologue to AIDS. The recognition of infectious opportunists. Medicine (Baltimore) 1998, 77:227–232.Google Scholar
  5. 5.
    Gottlieb MS, Schroff R, Schanker HM, et al.: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981, 305:1425–1431.CrossRefPubMedGoogle Scholar
  6. 6.
    Masur H, Michelis MA, Greene JB, et al.: An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981, 305:1431–1438.CrossRefPubMedGoogle Scholar
  7. 7.
    Dore GJ, Li Y, McDonald A, et al.: Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002, 29:388–395.PubMedGoogle Scholar
  8. 8.
    Ives NJ, Gazzard BG, Easterbrook PJ: The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect 2001, 42:134–139.CrossRefPubMedGoogle Scholar
  9. 9.
    Krentz HB, Kliewer G, Gill MJ: Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005, 6:99–106.CrossRefPubMedGoogle Scholar
  10. 10.
    McNally LM, Jeena PM, Lalloo U, et al.: Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infant. AIDS 2005, 19:1548–1549.CrossRefPubMedGoogle Scholar
  11. 11.
    Gerhart JL, Kalaaji AN: Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications. J Am Acad Dermatol 2010, 62:957–961.CrossRefPubMedGoogle Scholar
  12. 12.
    Contini C, Villa MP, Romani R, et al.: Detection of Pneumocystis carinii among children with chronic respiratory disorders in the absence of HIV infection and immunodeficiency. J Med Microbiol 1998, 47:329–333.CrossRefPubMedGoogle Scholar
  13. 13.
    Vargas SL, Hughes WT, Santolaya ME, et al.: Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001, 32:855–861.CrossRefPubMedGoogle Scholar
  14. 14.
    Aliouat-Denis CM, Martinez A, Aliouat el M, et al.: The Pneumocystis life cycle. Mem Inst Oswaldo Cruz 2009, 104:419–426.CrossRefPubMedGoogle Scholar
  15. 15.
    Beck JM, Cushion MT: Pneumocystis workshop: 10th anniversary summary. Eukaryot Cell 2009, 8:446–460.CrossRefPubMedGoogle Scholar
  16. 16.
    Casanova-Cardiel L, Leibowitz MJ: Presence of Pneumocystis carinii DNA in pond water. J Eukaryot Microbiol 1997, 44:28S.CrossRefPubMedGoogle Scholar
  17. 17.
    Wakefield AE: DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol 1996, 34:1754–1759.PubMedGoogle Scholar
  18. 18.
    Sinclair K, Wakefield AE, Banerji S, Hopkin JM: Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol Biochem Parasitol 1991, 45:183–184.CrossRefPubMedGoogle Scholar
  19. 19.
    Wakefield AE: Genetic heterogeneity in Pneumocystis carinii: an introduction. FEMS Immunol Med Microbiol 1998, 22:5–13.CrossRefPubMedGoogle Scholar
  20. 20.
    Gigliotti F, Harmsen AG, Haidaris CG, Haidaris PJ: Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun 1993, 61:2886–2890.PubMedGoogle Scholar
  21. 21.
    • Gianella S, Haeberli L, Joos B, et al.: Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis 2010, 12:1–10. This paper documents an outbreak of PCP among renal transplant recipients and describes the chain of transmission occurring during clinic visits and a shared patient waiting area. This is one of a small number of papers adding to the growing evidence of human-to-human transmission of Pneumocystis pneumonia; it has implications for prevention and control of infections among susceptible transplant populations.CrossRefPubMedGoogle Scholar
  22. 22.
    Hughes WT: Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis 1982, 145:842–848.PubMedGoogle Scholar
  23. 23.
    Walzer PD: Pneumocystis carinii infection. South Med J 1977, 70:1330–1337.PubMedGoogle Scholar
  24. 24.
    Beard CB, Carter JL, Keely SP, et al.: Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000, 6:265–272.CrossRefPubMedGoogle Scholar
  25. 25.
    Keely SP, Baughman RP, Smulian AG, et al.: Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 1996, 10:881–888.CrossRefPubMedGoogle Scholar
  26. 26.
    Miller RF, Lindley AR, Ambrose HE, et al.: Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom. Antimicrob Agents Chemother 2003, 47:3979–3981.CrossRefPubMedGoogle Scholar
  27. 27.
    Wakefield AE, Lindley AR, Ambrose HE, et al.: Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J Infect Dis 2003, 187:901–908.CrossRefPubMedGoogle Scholar
  28. 28.
    Elvin K, Olsson M, Lidman C, Bjorkman A: Detection of asymptomatic Pneumocystis carinii infection by polymerase chain reaction: predictive for subsequent pneumonia. AIDS 1996, 10:1296–1297.CrossRefPubMedGoogle Scholar
  29. 29.
    Leigh TR, Kangro HO, Gazzard BG, et al.: DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med 1993, 87:525–529.CrossRefPubMedGoogle Scholar
  30. 30.
    Peters SE, Wakefield AE, Sinclair K, et al.: A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol 1992, 166:195–198.CrossRefPubMedGoogle Scholar
  31. 31.
    Stansell JD, Osmond DH, Charlebois E, et al.: Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997, 155:60–66.PubMedGoogle Scholar
  32. 32.
    Aderaye G, Bruchfeld J, Aseffa G, et al.: Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia. Scand J Infect Dis 2007, 39:1045–1053.CrossRefPubMedGoogle Scholar
  33. 33.
    Ansari NA, Kombe AH, Kenyon TA, et al.: Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Int J Tuberc Lung Dis 2002, 6:55–63.PubMedGoogle Scholar
  34. 34.
    Krajicek BJ, Thomas CF, Jr., Limper AH: Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med 2009, 30:265–278.CrossRefPubMedGoogle Scholar
  35. 35.
    Gigliotti F, Harmsen AG, Wright TW: Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun 2003, 71:3852–3856.CrossRefPubMedGoogle Scholar
  36. 36.
    Leigh TR, Wakefield AE, Peters SE, et al.: Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation 1992, 54:468–470.CrossRefPubMedGoogle Scholar
  37. 37.
    Matos O, Costa MC, Correia I, et al.: [Pneumocystis jiroveci infection in immunocompetent patients with pulmonary disorders, in Portugal]. Acta Med Port 2006, 19:121–126.PubMedGoogle Scholar
  38. 38.
    Huang L, Morris A, Limper AH, Beck JM: An Official ATS Workshop Summary: Recent advances and future directions in Pneumocystis pneumonia (PCP). Proc Am Thorac Soc 2006, 3:655–664.CrossRefPubMedGoogle Scholar
  39. 39.
    Morris A, Kingsley LA, Groner G, et al.: Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004, 18:793–798.CrossRefPubMedGoogle Scholar
  40. 40.
    Lipschik GY, Gill VJ, Lundgren JD, et al.: Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet 1992, 340:203–206.CrossRefPubMedGoogle Scholar
  41. 41.
    Tamburrini E, Mencarini P, De Luca A, et al.: Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol 1993, 38:449–453.CrossRefPubMedGoogle Scholar
  42. 42.
    Larsen HH, Masur H, Kovacs JA, et al.: Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 2002, 40:490–494.CrossRefPubMedGoogle Scholar
  43. 43.
    • Helweg-Larsen J, Benfield T, Atzori C, Miller RF: Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. J Antimicrob Chemother 2009, 64:1282–1290. This is a cohort study comparing clinical success and requirements for second-line therapy among patients treated with three drugs for PCP. For patients in this cohort study, TMX remained the treatment of choice for patient survival; clindamycin/primaquine treatment yielded the highest survival rates for second-line treatments, and pentamidine yielded the lowest survival rates when used as either first-line or second-line therapy.CrossRefPubMedGoogle Scholar
  44. 44.
    World Health Organization: Guidelines on cotrimoxazole prophylaxis for HIV-related infections among children, adolescents, and adults in resource-limited settings. Recommendations for a public health approach. Geneva, Switzerland: WHO Press; 2006. Available at Accessed February 2, 2010.
  45. 45.
    Urschel S, Ramos J, Mellado M, et al.: Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy. AIDS 2005, 19:2103–2108.CrossRefPubMedGoogle Scholar
  46. 46.
    Hirsch HH, Kaufmann G, Sendi P, Battegay M: Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004, 38:1159–1166.CrossRefPubMedGoogle Scholar
  47. 47.
    Masur H, Kaplan JE, Holmes KK: Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002, 137:435–478.PubMedGoogle Scholar
  48. 48.
    Dykewicz CA: Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections. Biol Blood Marrow Transplant 2001, 7(Suppl):19S–22S.CrossRefPubMedGoogle Scholar
  49. 49.
    Anglaret X, Chene G, Attia A, et al.: Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d’Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 1999, 353:1463–1468.Google Scholar
  50. 50.
    Wiktor SZ, Sassan-Morokro M, Grant AD, et al.: Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d’Ivoire: a randomised controlled trial. Lancet 1999, 353:1469–1475.CrossRefPubMedGoogle Scholar
  51. 51.
    Kazanjian P, Locke AB, Hossler PA, et al.: Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998, 12:873–878.CrossRefPubMedGoogle Scholar
  52. 52.
    Kazanjian P, Armstrong W, Hossler PA, et al.: Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000, 182:551–557.CrossRefPubMedGoogle Scholar
  53. 53.
    Crothers K, Beard CB, Turner J, et al.: Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005, 19:801–805.CrossRefPubMedGoogle Scholar
  54. 54.
    Navin TR, Beard CB, Huang L, et al.: Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 2001, 358:545–549.CrossRefPubMedGoogle Scholar
  55. 55.
    Helweg-Larsen J, Jensen JS, Benfield T, et al.: Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 1998, 36:2068–2072.PubMedGoogle Scholar
  56. 56.
    • Gupta R, Mirdha BR, Guleria R, et al.: Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens. Diagn Microbiol Infect Dis 2009, 64:381–388. This article describes a highly sensitive and specific nested PCR assay for the detection of Pneumocystis DNA using a variety of clinical samples. Existing diagnostics for PCP are poor and frequently lack sensitivity, even when involving invasive specimens; a highly sensitive diagnostic assay could help detect early-stage disease.CrossRefPubMedGoogle Scholar
  57. 57.
    Ribes JA, Limper AH, Espy MJ, Smith TF: PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 1997, 35:830–835.PubMedGoogle Scholar
  58. 58.
    Matos O, Costa MC, Lundgren B, et al.: Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis 2001, 20:573–575.CrossRefPubMedGoogle Scholar
  59. 59.
    Larsen HH, Huang L, Kovacs JA, et al.: A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 2004, 189:1679–1683.CrossRefPubMedGoogle Scholar
  60. 60.
    McNaghten AD, Hanson DL, Jones JL, et al.: Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 1999, 13:1687–1695.Google Scholar
  61. 61.
    Kelley CF, Checkley W, Mannino DM, et al.: Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii pneumonia in the United States (1986 to 2005). Chest 2009, 136:190–197.CrossRefPubMedGoogle Scholar
  62. 62.
    Fei MW, Kim EJ, Sant CA, et al.: Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 2009, 64:1070–1076.CrossRefPubMedGoogle Scholar
  63. 63.
    Arichi N, Kishikawa H, Mitsui Y, et al.: Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc 2009, 41:170–172.CrossRefPubMedGoogle Scholar
  64. 64.
    de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, et al.: An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis 2007, 44:1143–1149.CrossRefPubMedGoogle Scholar
  65. 65.
    Yazaki H, Goto N, Uchida K, et al.: Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation 2009, 88:380–385.CrossRefPubMedGoogle Scholar
  66. 66.
    Hocker B, Wendt C, Nahimana A, et al.: Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg Infect Dis 2005, 11:330–332.PubMedGoogle Scholar
  67. 67.
    Pappas PG, Alexander BD, Andes DR, et al.: Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010, 50:1101–1111.CrossRefPubMedGoogle Scholar
  68. 68.
    Neff RT, Jindal RM, Yoo DY, et al.: Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 2009, 88:135–141.CrossRefPubMedGoogle Scholar
  69. 69.
    Abouya YL, Beaumel A, Lucas S, et al.: Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 1992, 145:617–620.PubMedGoogle Scholar
  70. 70.
    Atzori C, Bruno A, Chichino G, et al.: Pneumocystis carinii pneumonia and tuberculosis in Tanzanian patients infected with HIV. Trans R Soc Trop Med Hyg 1993, 87:55–56.CrossRefPubMedGoogle Scholar
  71. 71.
    Carme B, Mboussa J, Andzin M, et al.: Pneumocystis carinii is rare in AIDS in Central Africa. Trans R Soc Trop Med Hyg 1991, 85:80.CrossRefPubMedGoogle Scholar
  72. 72.
    Elvin KM, Lumbwe CM, Luo NP, et al.: Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia. Trans R Soc Trop Med Hyg 1989, 83:553–555.CrossRefPubMedGoogle Scholar
  73. 73.
    McLeod DT, Neill P, Robertson VJ, et al.: Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans R Soc Trop Med Hyg 1989, 83:694–697.CrossRefPubMedGoogle Scholar
  74. 74.
    Serwadda D, Goodgame R, Lucas S, Kocjan G: Absence of pneumocystosis in Ugandan AIDS patients. AIDS 1989, 3:47–48.PubMedGoogle Scholar
  75. 75.
    Aderaye G, Bruchfeld J, Olsson M, Lindquist L: Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia. AIDS 2003, 17:435–440.CrossRefPubMedGoogle Scholar
  76. 76.
    Hargreaves NJ, Kadzakumanja O, Phiri S, et al.: Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg 2001, 95:402–408.CrossRefPubMedGoogle Scholar
  77. 77.
    Worodria W, Okot-Nwang M, Yoo SD, Aisu T: Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear–negative. Int J Tuberc Lung Dis 2003, 7:117–123.PubMedGoogle Scholar
  78. 78.
    Chakaya JM, Bii C, Ng’ang’a L, et al.: Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya. East Afr Med J 2003, 80:30–35.PubMedGoogle Scholar
  79. 79.
    Ikeogu MO, Wolf B, Mathe S: Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997, 76:124–128.CrossRefPubMedGoogle Scholar
  80. 80.
    Jeena PM, Coovadia HM, Chrystal V: Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr 1996, 16:361–368.PubMedGoogle Scholar
  81. 81.
    Lucas SB, Peacock CS, Hounnou A, et al.: Disease in children infected with HIV in Abidjan, Cote d’Ivoire. BMJ 1996, 312:335–338.PubMedGoogle Scholar
  82. 82.
    Malin AS, Gwanzura LK, Klein S, et al.: Pneumocystis carinii pneumonia in Zimbabwe. Lancet 1995, 346:1258–1261.CrossRefPubMedGoogle Scholar
  83. 83.
    Fisk DT, Meshnick S, Kazanjian PH: Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 2003, 36:70–78.CrossRefPubMedGoogle Scholar
  84. 84.
    •• Morrow BM, Hsaio NY, Zampoli M, et al.: Pneumocystis pneumonia in South African children with and without human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Pediatr Infect Dis J 2010, 29:535–539. This study of 202 hospitalized children with pneumonia examined the incidence and outcomes of PCP among pediatric patients in an area of South Africa with high HIV prevalence, where Prevention of Mother to Child Transmission (PMTCT) programs and HAART were freely available. Overall, 21% of children (both HIV-infected and uninfected) who were admitted with hypoxic pneumonia were positive for PCP, a proportion similar to the pre-HAART era; survival was poor. Results from this study suggest that PCP remains a significant cause of pediatric pneumonia in South Africa in spite of global advances in PMTCT and HAART.PubMedGoogle Scholar
  85. 85.
    Lumbiganon P, Kosalaraksa P, Loapaiboon M: Survival of children with AIDS: experience in a university hospital in northeast Thailand. J Med Assoc Thai 2000, 83:652–656.PubMedGoogle Scholar
  86. 86.
    Wannamethee SG, Sirivichayakul S, Phillips AN, et al.: Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Int J Epidemiol 1998, 27:289–295.CrossRefPubMedGoogle Scholar
  87. 87.
    Sritangratanakul S, Nuchprayoon S, Nuchprayoon I: Pneumocystis pneumonia: an update. J Med Assoc Thai 2004, 87(Suppl 2):S309–317.PubMedGoogle Scholar
  88. 88.
    Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson KE: Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994–1998: regional variation and temporal trends. Clin Infect Dis 2001, 32:955–962.CrossRefPubMedGoogle Scholar
  89. 89.
    • Kitkungvan D, Apisarnthanarak A, Plengpart P, Mundy LM: Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS 2008, 19:232–235. This study highlights the burden of PCP in an Asian country among patients with fever of unknown origin. Mortality was associated with inadequate antimicrobial treatment, highlighting the need for continuing and innovative public health interventions to combat a disease for which prophylaxis and treatment have long been available.CrossRefPubMedGoogle Scholar
  90. 90.
    Bhoopat L, Thamprasert K, Chaiwun B, et al.: Histopathologic spectrum of AIDS-associated lesions in Maharaj Nakorn Chiang Mai Hospital. Asian Pac J Allergy Immunol 1994, 12:95–104.PubMedGoogle Scholar
  91. 91.
    Nissapatorn V, Lee C, Fatt QK, Abdullah KA: AIDS-related opportunistic infections in Hospital Kuala Lumpur. Jpn J Infect Dis 2003, 56:187–192.PubMedGoogle Scholar
  92. 92.
    Le Minor O, Germani Y, Chartier L, et al.: Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumonia. J Acquir Immune Defic Syndr 2008, 48:620–627.CrossRefPubMedGoogle Scholar
  93. 93.
    Senya C, Mehta A, Harwell JI, et al.: Spectrum of opportunistic infections in hospitalized HIV-infected patients in Phnom Penh, Cambodia. Int J STD AIDS 2003, 14:411–416.CrossRefPubMedGoogle Scholar
  94. 94.
    Kong BN, Harwell JI, Suos P, et al.: Opportunistic infections and HIV clinical disease stage among patients presenting for care in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health 2007, 38:62–68.PubMedGoogle Scholar
  95. 95.
    Soares VY, Lucio Filho CE, Carvalho LI, et al.: Clinical and epidemiological analysis of patients with HIV/AIDS admitted to a reference hospital in the northeast region of Brazil. Rev Inst Med Trop Sao Paulo 2008, 50:327–332.PubMedGoogle Scholar
  96. 96.
    Soares EC, Saraceni V, Lauria Lde M, et al.: Tuberculosis as a disease defining acquired immunodeficiency syndrome: ten years of surveillance in Rio de Janeiro, Brazil. J Bras Pneumol 2006, 32:444–448.PubMedGoogle Scholar
  97. 97.
    Perez E, Toibaro JJ, Losso MH: [HIV patient hospitalization during the pre and post-HAART era]. Medicina (B Aires) 2005, 65:482–488.Google Scholar
  98. 98.
    Fallo AA, DobrzanskiNisiewicz W, Sordelli N, et al.: Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina. Int J Infect Dis 2002, 6:9–16.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Julie R. Harris
    • 1
  • S. Arunmozhi Balajee
    • 1
  • Benjamin J. Park
    • 1
  1. 1.Centers for Disease Control and PreventionAtlantaUSA

Personalised recommendations